Use of fullerenes in diagnostic and/or therapeutic agents
Patent 5688486 Issued on November 18, 1997. Estimated Expiration Date: 
November 18, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 18, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesProcess of forming polysubstituted fullerenes Fullerene compositions for magnetic resonance spectroscopy and imaging Patent #: 5248498 InventorsAssigneeApplicationNo. 284606 filed on 10/31/1994US Classes:424/1.65, In an organic compound424/9.36, Transition, actinide, or lanthanide metal containing424/9.42Transition, actinide, or lanthanide metal containingExaminersPrimary: Seidleck, James J.Assistant: Williamson, Michael A. Attorney, Agent or FirmInternational ClassA61K 051/00Foreign Application Priority Data1992-02-11 GBAbstractCompounds including tight molecular meshes, preferably curved in one or two directions, such as fullerenes and met-cars, can be used as carriers for diagnostic or therapeutic agents, especially diagnostic contrast agents.Field of SearchIn an organic compoundHalogen Fluorine Transition, actinide, or lanthanide metal containing Transition, actinide, or lanthanide metal containing Ultrasound contrast agent IN VIVO DIAGNOSIS OR IN VIVO TESTING RARE EARTH COMPOUND (AT. NO. 21, 39, OR 57-71) Plural carbocyclic rings containing RARE EARTH METAL CONTAINING (At. No. 21, 39, 57-60 or 62-71) | |
